Hospital Universitari Son Espases,

Palma de Mallorca, Balearic Islands 7010

0 studies enrolling now · 16 studies all time

What they study most

Brain Contusion, Branch Retinal Vein Occlusion, Breast Cancer, Breast Neoplasms, Cancer of the Prostate, Central Retinal Vein Occlusion, Diabetic Macular Edema, Giant Cell Tumor of Bone, Hemi-retinal Vein Occlusion, Hemophilia A, Hormone Sensitive Prostate Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer

Studies at this site

• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion — Stopped early
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 — Completed
• Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• BAX 855 PK-guided Dosing — Completed
• BAX 855 Continuation — Completed
• Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures — Completed
• Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study) — Completed